Novel copper complexes with potent/synergistic antitumor activity in vivo and promising clinical activity

被引:0
|
作者
Prokop, A.
Zadolinnaya, S.
Abduvaliev, A.
Frias, C.
Hagenow, K.
Voigt, A.
Tatarskiy, V.
机构
[1] City Cologne, Childrens Hosp, Dept Pediat Oncol Hematol, Cologne, Germany
[2] Univ Potsdam, Inst Chem, Potsdam, Germany
[3] Natl Acad Sci, Inst Oncol & Radiol, Tashkent, Uzbekistan
[4] Ipal Gesell Fuer Patentverwertung Berlin mbH, Berlin, Germany
[5] Charite, Dept Pediat Oncol Hematol, D-13353 Berlin, Germany
关键词
D O I
10.1200/jco.2011.29.15_suppl.e13518
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13518
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Synthesis of novel diterpenoid analogs with in-vivo antitumor activity
    Wang, Ying-Ying
    He, Yuan
    Yang, Lian-Fang
    Peng, Shi-Hong
    He, Xiao-Long
    Wang, Jin-Hua
    Lv, Fang
    Hao, Yun
    Liu, Ming-Yao
    Yi, Zhengfang
    Qiu, Wen-Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 120 : 13 - 25
  • [42] In vivo antitumor activity of novel water-soluble taxoids
    Mikuni, Katsuhiko
    Nakanishi, Katsuyoshi
    Hara, Koji
    Hara, Kozo
    Iwatani, Wakao
    Amano, Tetsuya
    Nakamura, Kosho
    Tsuchiya, Yoshinori
    Okumoto, Hiroshi
    Mandai, Tadakatsu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (06) : 1155 - 1158
  • [43] Novel ADC platform delivers promising in vivo activity and safety
    Liu, Haidong
    Qi, Wenke
    Wang, Lei
    Wang, Guobao
    Chen, Xinyue
    Gavrilyuk, Julia
    Han, Tae
    Zhao, Baiteng
    Shang, Xiao
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Novel Quinoline-based Ir(III) Complexes Exhibit High Antitumor Activity in Vitro and in Vivo
    Yang, Yan
    Bin, Yi-Dong
    Qin, Qi-Pin
    Luo, Xu-Jian
    Zou, Bi-Qun
    Zhang, Hua-Xin
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12): : 1614 - 1619
  • [45] Antitumor activity of synthetic three copper(II) complexes with terpyridine ligands
    Yang, Yang
    Guo, Fei-Fei
    Chen, Cai-Feng
    Li, Yu-Lan
    Liang, Hong
    Chen, Zhen-Feng
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2023, 240
  • [46] Synthesis and antitumor activity of new methylglyoxal and glucosone bisthiosemicarbazones and their copper complexes
    Dilanyan E.R.
    Ovsepyan T.R.
    Stepanyan G.M.
    Pharmaceutical Chemistry Journal, 2000, 34 (8) : 408 - 410
  • [47] A novel, potent inhibitor of Src family kinases with in vivo activity
    Boschelli, Frank
    Golas, Jennifer M.
    Golas, Jonathan
    Lucas, Judy
    Discafani, Carolyn
    Arndt, Kim
    Boschelli, Diane
    CANCER RESEARCH, 2006, 66 (08)
  • [48] D-1553: A novel KRASG12C inhibitor with potent and selective cellular and in vivo antitumor activity
    Shi, Zhe
    Weng, Jifang
    Niu, Haotao
    Yang, Hong
    Liu, Rongfeng
    Weng, Yan
    Zhu, Qingqing
    Zhang, Yihong
    Tao, Liangshan
    Wang, Zhenwu
    Huh, Seok Jae
    Jiang, Yueheng
    Mei, Hong
    Dai, Xing
    Zhang, Ling
    Wang, Yaolin
    CANCER SCIENCE, 2023, 114 (07) : 2951 - 2960
  • [49] Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity
    Yun, Fan
    Cheng, Chunhui
    Ullah, Sadeeq
    He, Jie
    Zahi, Mohamed Reda
    Yuan, Qipeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 : 195 - 207
  • [50] In vivo antitumor activity of NVP-AEW541 -: A novel, potent, and selective inhibitor of the IGF-IR kinase
    García-Echeverría, C
    Pearson, MA
    Marti, A
    Meyer, T
    Mestan, J
    Zimmermann, J
    Gao, JP
    Brueggen, J
    Capraro, HG
    Cozens, R
    Evans, DB
    Fabbro, D
    Furet, P
    Porta, DG
    Liebetanz, J
    Martiny-Baron, G
    Ruetz, S
    Hofmann, F
    CANCER CELL, 2004, 5 (03) : 231 - 239